SPY425.94+0.84 0.20%
DIA343.69+1.71 0.50%
IXIC14,376.17+6.46 0.04%

--Morgan Stanley Adjusts Price Target on Insmed to $56 From $58, Maintains Overweight Rating

05/10/2021 07:10

10:57 AM EDT, 05/10/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 26.84, Change: -5.74, Percent Change: -17.62